Mettler-Toledo International (NYSE:MTD) Raised to Outperform at Evercore ISI

Evercore ISI upgraded shares of Mettler-Toledo International (NYSE:MTD) from an in-line rating to an outperform rating in a report released on Thursday, Marketbeat Ratings reports. They currently have $1,450.00 price objective on the medical instruments supplier’s stock, up from their previous price objective of $1,375.00.

Other equities research analysts have also recently issued research reports about the company. Robert W. Baird dropped their price objective on Mettler-Toledo International from $1,375.00 to $1,310.00 and set a “neutral” rating on the stock in a research note on Monday, November 11th. Wells Fargo & Company dropped their price target on shares of Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating on the stock in a research report on Monday, November 11th. Stifel Nicolaus decreased their price objective on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a research report on Monday, November 11th. Citigroup raised shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their target price for the company from $1,200.00 to $1,300.00 in a report on Wednesday, December 11th. Finally, Wolfe Research initiated coverage on Mettler-Toledo International in a report on Friday, December 13th. They set a “peer perform” rating for the company. One analyst has rated the stock with a sell rating, six have given a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International currently has a consensus rating of “Hold” and an average target price of $1,351.25.

Mettler-Toledo International Trading Down 0.2 %

Shares of MTD stock opened at $1,220.78 on Thursday. The firm’s fifty day moving average price is $1,258.07 and its two-hundred day moving average price is $1,357.66. Mettler-Toledo International has a 1 year low of $1,115.64 and a 1 year high of $1,546.93. The firm has a market capitalization of $25.76 billion, a P/E ratio of 32.91, a PEG ratio of 4.21 and a beta of 1.13.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. The company had revenue of $954.54 million during the quarter, compared to analysts’ expectations of $941.93 million. As a group, equities research analysts forecast that Mettler-Toledo International will post 40.42 EPS for the current fiscal year.

Insider Activity at Mettler-Toledo International

In other news, Director Elisha W. Finney sold 76 shares of the business’s stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $1,311.75, for a total transaction of $99,693.00. Following the completion of the sale, the director now owns 240 shares in the company, valued at $314,820. The trade was a 24.05 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Gerry Keller sold 140 shares of the stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total value of $175,572.60. Following the transaction, the insider now owns 6 shares in the company, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their position. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Institutional Investors Weigh In On Mettler-Toledo International

A number of institutional investors have recently modified their holdings of the business. Blue Trust Inc. raised its stake in Mettler-Toledo International by 242.9% in the 3rd quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock worth $34,000 after purchasing an additional 17 shares in the last quarter. Ashton Thomas Securities LLC acquired a new stake in shares of Mettler-Toledo International in the third quarter valued at approximately $37,000. Rothschild Investment LLC bought a new stake in shares of Mettler-Toledo International in the second quarter valued at approximately $42,000. Itau Unibanco Holding S.A. bought a new stake in shares of Mettler-Toledo International in the second quarter valued at approximately $42,000. Finally, Raleigh Capital Management Inc. grew its position in Mettler-Toledo International by 272.7% during the third quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock worth $61,000 after buying an additional 30 shares in the last quarter. Institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.